John K Fraser

This inventor holds 35 USPTO granted patents and 24 published patent applications, plus 4 CIPO patents and 17 EPO patents, primarily in Regenerative Medicine. Top assignee: Cytori Therapeutics, Inc.. Active years: 2008-2018.

USPTO Granted Patents = 35 (Patent Applications = 24)

% Patents Active = 31.4

CIPO Patents = 4 (Patent Applications = 4)

EPO Patents = 17 (Patent Applications = 14)

Average Co-Inventor Count = 2.7

ph-index = 18

Forward Citations = 1,704(Granted Patents)

Location History:

Los Angeles, CA (US) (2008 - 2014)
San Diego, CA (US) (2009 - 2018)

Company Filing History:

35 out of 38

Cytori Therapeutics, Inc.

patents

Years Active: 2008-2018

Loading Chart...

Areas of Expertise:

Adipose-Derived Cells

Regenerative Cells

Wound Healing

Cardiovascular Treatment

Musculoskeletal Disorders

Erectile Dysfunction

Neodermis Formation

Ischemic Wound

Fat Transfer

Liver Injury

Peripheral Vascular Disease

Stem Cell Processing

35 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10119113 - Systems for isolating and using clinically safe adipose derived regenerative cells (2018-11-06),

2. 9872877 - Methods of using regenerative cells to promote epithelialization or neodermis formation (2018-01-23),

3. 9849149 - Methods of using regenerative cells in the treatment of erectile dysfunction (2017-12-26),

4. 9597395 - Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions (2017-03-21),

5. 9511096 - Methods of using regenerative cells to treat an ischemic wound (2016-12-06),

6. 9511094 - Methods of using regenerative cells in the treatment of stroke and related diseases and disorders (2016-12-06),

7. 9504718 - Methods of using adipose derived regenerative cells in the treatment of renal diseases and disorders (2016-11-29),

8. 9504716 - Methods of using adipose derived regenerative cells to promote restoration of intevertebral disc (2016-11-29),

9. 9492483 - Methods of using regenerative cells to treat a burn (2016-11-15),

10. 9486484 - Methods of using adipose tissue-derived cells in the treatment of the lymphatic system and malignant disease (2016-11-08),

11. 9480718 - Methods of using adipose-derived regenerative cells in the treatment of peripheral vascular disease and related disorders (2016-11-01),

12. 9463203 - Methods of using regenerative cells in the treatment of cartilage defects (2016-10-11),

13. 9198937 - Adipose-derived regenerative cells for treating liver injury (2015-12-01),

14. 8883499 - Systems and methods for isolating and using clinically safe adipose derived regenerative cells (2014-11-11),

15. 8784801 - Methods of using adipose tissue-derived cells in the treatment of the lymphatic system and malignant disease (2014-07-22),

Title: John K. Fraser: Innovator in Regenerative Medicine

Introduction

John K. Fraser is an accomplished inventor based in San Diego, California, known for his significant contributions to the field of regenerative medicine. With an impressive portfolio of 35 patents, Fraser has been at the forefront of innovations that utilize adipose-derived regenerative cells for therapeutic applications.

Latest Patents

Fraser's recent patents focus on systems and methods for isolating clinically safe adipose-derived regenerative cells. One notable patent describes automated processes that efficiently separate regenerative cells, including stem and progenitor cells, from adipose tissue. These methods not only ensure rapid extraction but also guarantee the reliability of the cells for re-infusion into patients. Another critical patent presents techniques for utilizing regenerative cells from adipose tissue to promote wound healing in patients. This methodology allows for the delivery of concentrated regenerative cells directly into a subject, thereby enhancing the therapeutic benefits through a closed system that minimizes exposure to external environments.

Career Highlights

Fraser's dedication to the field is exemplified through his work at Cytori Therapeutics, Inc., where he has played a pivotal role in advancing innovations in regenerative therapy. His patents reflect a keen insight into the medical applications of adipose tissue and regenerative cells, ultimately aiming to improve patient outcomes in wound healing and tissue regeneration.

Collaborations

Throughout his career, Fraser has collaborated with notable colleagues in the field, including Marc H. Hedrick and Eric Daniels. These partnerships have enriched his research endeavors and contributed to the collective advancements in regenerative medicine.

Conclusion

John K. Fraser's contributions to the medical field through his inventions and patents underscore the importance of innovation in regenerative therapies. His work continues to pave the way for future advancements, enhancing the possibilities of healing and recovery for patients across various medical conditions.